Global Pleural Effusion Market Overview
As per MRFR analysis, the Pleural Effusion Market Size was estimated at 3.23 (USD Billion) in 2022.
The Pleural Effusion Market Industry is expected to grow from 3.39(USD Billion) in 2023 to 5.2 (USD Billion) by 2032. The Pleural Effusion Market CAGR (growth rate) is expected to be around 4.88% during the forecast period (2024 - 2032).
Key Pleural Effusion Market Trends Highlighted
The global market for pleural effusion is driven by several key factors, including the increasing prevalence of pleural diseases, such as pneumonia and lung cancer, the growing adoption of minimally invasive procedures for pleural effusion drainage, and the rising demand for effective and safe treatment options.Opportunities for growth in the pleural effusion market lie in the development of novel diagnostic and therapeutic approaches, such as image-guided pleural procedures and targeted drug delivery systems. Additionally, the unmet medical needs of patients with pleural effusion, including those with refractory or recurrent effusions, present significant opportunities for innovation.
Recent trends in the market include the increasing use of ultrasound-guided pleural procedures, which offer greater accuracy and safety compared to traditional blind techniques. Advancements in pleural fluid analysis, including the use of biomarkers and molecular diagnostics, are also contributing to improved patient outcomes. Furthermore, the growing awareness of pleural effusion as a potential complication of various medical conditions is driving the demand for early diagnosis and effective management strategies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pleural Effusion Market Drivers
Rising Prevalence of Pleural Effusions
The growing incidence of pleural effusions affects the market substantially. Pleural effusions are accumulations of fluid in the pleural space, an area between the lungs and chest wall. They can result from a range of conditions, such as pneumonia, heart failure, and cancer. While some of them relate to the existing habits in the population, such as smoking or workplace hazards, others will become more prominent with the population aging. Thus, the growing proportion of elderly people associated with the overall worldwide aging tendency might increase the number of pleural effusions.As the existing population reaches a greater age and the new generations grow older, the cases attributable to heart failure, cancer, chronic kidney diseases and cirrhosis, among others, are also inclined to enhance. Additionally, obesity, a rising problem in a variety of regions, is a risk factor associated with the incidence of heart failure, which will also increase the number of pleural effusions. Thus, the growing number of individuals developing these accumulations will present a concern for populations across the globe; the condition may be incapacitating and life-threatening, which results in a need for efficient solutions.
Technological Advancements
Aside from increased demand, technological advancements are the other major drivers of growth in the Pleural Effusion Market Industry. Over the past several years, there have been extensive improvements in the development of new diagnostic and treatment methods for pleural effusions. These technological advancements have significantly improved the care of patients and reduced costs. As such, one of the most important technological advancements in the field of pleural effusion management has been the development of new imaging techniques.Such techniques, such as computed tomography and magnetic resonance imaging, allow doctors to observe the pleural space and establish the cause of the effusion. In turn, the provided information is vital for the formulation of an appropriate treatment plan. In addition, another important technological advancement has been the development of new drainage techniques. The latter, which includes thoracentesis and pleurodesis, provides physicians with the opportunity to remove the fluid from the pleural space and avoid reaccumulation. Consequently, the developed techniques have effectively improved the outcomes of pleural effusion patients.
Growing Awareness
Growing awareness of pleural effusions is also contributing to market growth. In the past, pleural effusions were often misdiagnosed or underdiagnosed. This was due to a lack of awareness of the condition and its symptoms. However, in recent years, there has been a growing awareness of pleural effusions among both patients and healthcare professionals. This increased awareness is due in part to the efforts of patient advocacy groups and healthcare organizations.These groups have worked to educate the public about pleural effusions and to promote early diagnosis and treatment. As a result of these efforts, more people are being diagnosed with pleural effusions and are receiving the treatment they need.
Pleural Effusion Market Segment Insights
Pleural Effusion Market Type Insights
The growth of the market is primarily attributable to the increasing prevalence of pleural effusion and the surging demand for advanced diagnostic and therapeutic procedures. The market is segregated based on type into transudative pleural effusion and exudative pleural effusion. While transudative pleural effusion is induced by an imbalance of hydrostatic and osmotic pressures, the exudative variety is caused due to inflammation or infection. Owing to the higher prevalence of inflammatory and infectious diseases, the exudative pleural effusion segment is anticipated to capture a larger share of the market.The leading players of the Pleural Effusion Market are Becton, Dickinson and Company, Cook Medical, Inc., Merit Medical Systems, Inc., and Teleflex Incorporated. The companies are adopting strategies such as the development of innovative products and technologies to enhance the diagnosis and treatment of pleural effusion. Additionally, the growth of the market has benefited from the surging adoption of point-of-care testing devices. These devices facilitate quick and precise diagnosis of pleural effusion, consequently leading to the timely administration of appropriate treatment.The demand for minimally invasive procedures for the management of pleural effusion is also propelling the growth of the market. Overall, the Pleural Effusion Market is slated to exhibit profitable growth over the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pleural Effusion Market Etiology Insights
Pleural Effusion Market is segmented into infectious, cardiac, pulmonary, malignant, and miscellaneous etiologies. In 2023, the malignant etiology is expected to hold the largest market share, and the segment is also expected to continue its domination over the forecast period. The rising incidence of lung cancer and other malignancies is the major factor propelling the growth of malignant etiology. The infectious etiology segment is also expected to grow significantly as the prevalence of pneumonia and other respiratory infections continues to increase.Overall demand for minimally invasive procedures for the management of pleural effusion is driving the growth of the Pleural Effusion Market.
Pleural Effusion Market Procedure Insights
The Pleural Effusion Market is segmented by Procedure into Thoracentesis, Pleural Drainage, Pleurodesis, and Thoracotomy. Thoracentesis is a minimally invasive procedure performed to remove fluid from the pleural space and is expected to hold a significant share of the market in 2024. Pleural Drainage is another commonly performed procedure involving the insertion of a chest tube to drain excess fluid. Pleurodesis is a surgical procedure that obliterates the pleural space to prevent re-accumulation of fluid and is projected to witness steady growth over the forecast period.Thoracotomy, a more invasive surgical procedure, is typically performed for complex cases and is expected to account for a smaller share of the market. The Pleural Effusion Market is driven by the increasing prevalence of pleural effusion, technological advancements in diagnostic and therapeutic procedures, and the rising geriatric population.
Pleural Effusion Market End-User Insights
The end-user segment of the Pleural Effusion Market plays a critical role in driving market growth. Hospitals account for a substantial share of the market, owing to the increasing prevalence of pleural effusions and the availability of advanced diagnostic and treatment facilities. Ambulatory surgery centers are gaining popularity for pleural effusion management due to their cost-effectiveness and convenience. Clinics are also contributing to the market growth by providing specialized care and follow-up services for patients with pleural effusions.Overall, the increasing demand for minimally invasive procedures, technological advancements, and the rising geriatric population are expected to fuel the growth of the Pleural Effusion Market in the coming years.
Pleural Effusion Market Regional Insights
The Pleural Effusion Market is segmented regionally into North America, Europe, APAC, South America, and MEA. North America is expected to account for the largest market share in 2024 due to the high prevalence of pleural effusion and the increasing adoption of advanced diagnostic and therapeutic techniques. The Asia-Pacific region is expected to witness the fastest growth over the forecast period due to the rising incidence of pleural effusion and the growing awareness of the condition.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pleural Effusion Market Key Players And Competitive Insights
Major players in the Pleural Effusion Market industry are constantly striving to gain a competitive edge by introducing innovative products and expanding their geographical reach. Leading Pleural Effusion Market players are focusing on strategic collaborations and partnerships to enhance their product portfolios and distribution channels. The Pleural Effusion Market Competitive Landscape is characterized by intense competition among established players and emerging entrants. These companies are investing heavily in research and development to stay ahead in the market. The Pleural Effusion Market development is driven by factors such as the rising prevalence of chronic diseases, the growing geriatric population, and increasing awareness about pleural effusion.Among the leading players in the Pleural Effusion Market, Stryker Corporation holds a significant market share. The company offers a comprehensive range of pleural effusion management products, including chest drains, drainage systems, and accessories. Stryker Corporation's strong brand recognition, extensive distribution network, and commitment to innovation have contributed to its leadership position in the market. The company continues to invest in research and development to enhance its product offerings and stay ahead of the competition.A notable competitor in the Pleural Effusion Market is Teleflex Incorporated. The company offers a range of pleural effusion management products under its Arrow brand. Teleflex Incorporated's focus on developing innovative and user-friendly products has enabled it to gain a strong customer base. The company's commitment to customer service and its global presence have contributed to its competitive position in the market. Teleflex Incorporated is actively involved in strategic partnerships and acquisitions to expand its product portfolio and geographical reach.
Key Companies in the Pleural Effusion Market Include
- Terumo Corporation
- Zimmer Biomet Holdings
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cygnus Medical
- Ethicon US, LLC
- Smiths Medical
- Toray Industries
- Cook Medical
- GE Healthcare
- Teleflex Incorporated
- Olympus Corporation
- Vasmed Inc.
- Medtronic
- Johnson Johnson
Pleural Effusion Market Industry Developments
The Pleural Effusion Market is projected to reach USD 5.2 billion by 2032, exhibiting a CAGR of 4.88% during the forecast period (2024-2032). The increasing prevalence of pleural effusion, rising demand for minimally invasive procedures, and technological advancements in diagnostic and therapeutic techniques drive market growth. Key market players include Medtronic, Boston Scientific, and Terumo Medical Corporation. Recent advancements include the development of novel drainage systems and the use of artificial intelligence in pleural effusion diagnosis and management. The market is expected to witness the emergence of new technologies and strategic collaborations in the coming years.
Pleural Effusion Market Segmentation Insights
- Pleural Effusion Market Type Outlook
- Transudative Pleural Effusion
- Exudative Pleural Effusion
- Pleural Effusion Market Etiology Outlook
- Infectious
- Cardiac
- Pulmonary
- Malignant
- Miscellaneous
- Pleural Effusion Market Procedure Outlook
- Thoracentesis
- Pleural Drainage
- Pleurodesis
- Thoracotomy
- Pleural Effusion Market End-User Outlook
- Hospitals
- Ambulatory Surgery Centers
- Clinics
| Report Attribute/Metric |
Details |
| Market Size 2022 |
3.23(USD Billion) |
| Market Size 2023 |
3.39(USD Billion) |
| Market Size 2032 |
5.2(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
4.88% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Terumo Corporation, Zimmer Biomet Holdings, Becton, Dickinson and Company, Boston Scientific Corporation, Cygnus Medical, Ethicon US, LLC, Smiths Medical, Toray Industries, Cook Medical, GE Healthcare, Teleflex Incorporated, Olympus Corporation, Vasmed Inc., Medtronic, Johnson Johnson |
| Segments Covered |
Type, Etiology, Procedure, End-User, Regional |
| Key Market Opportunities |
Targeted drug delivery systems Advanced imaging techniques Minimally invasive surgical approaches Increasing prevalence of pleural effusion Growing geriatric population |
| Key Market Dynamics |
Aging Population Technological Advancements Rising Prevalence of Chronic Diseases Increase in Diagnostic Procedures Growing Awareness and Education |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Pleural Effusion Market size is expected to grow from USD 3.39 billion in 2023 to USD 5.2 billion by 2032, at a CAGR of 4.88%.
North America is expected to dominate the Pleural Effusion Market in 2023, accounting for a share of over 40%.
The increasing prevalence of pleural effusion, the growing geriatric population, and the rising demand for minimally invasive procedures are major factors driving the growth of the Pleural Effusion Market.
Pleural effusion is primarily used for the diagnosis and management of pleural diseases, such as pleural effusion, pneumothorax, and empyema.
Major players in the Pleural Effusion Market include Medtronic, Johnson Johnson, Cardinal Health, Terumo Medical Corporation, and Teleflex.
The Pleural Effusion Market is expected to grow at a CAGR of 4.88% from 2024 to 2032.
Challenges faced by the Pleural Effusion Market include the high cost of procedures, the lack of skilled healthcare professionals, and the limited availability of advanced technologies in developing countries.
Opportunities for growth in the Pleural Effusion Market include the development of new and innovative technologies, the increasing adoption of minimally invasive procedures, and the rising demand for personalized medicine.
Key trends in the Pleural Effusion Market include the increasing use of image-guided procedures, the development of new drug therapies, and the growing focus on patient-centered care.
The COVID-19 pandemic has had a negative impact on the Pleural Effusion Market due to the postponement of elective procedures and the diversion of healthcare resources to COVID-19 patients.
